GO2 Foundation for Lung Cancer’s recently published scientific paper found that lung cancer screening programs can successfully detect lung cancer early with the majority of lung cancers diagnosed at stage 1 or limited stage. Importantly, outcomes at academic and nonacademic sites were compared and the data confirmed that responsible screening can take place in a community setting.

Figure B: Percentage of each stage and type of lung cancer diagnosed at nonacademic centers compared with academic centers.

Published in the respected Journal of Oncology Practice, the paper resulted from data collection from our Screening Centers of Excellence (SCOE) network. This is one of the first publications assessing workflow, outcomes, and barriers at community-based lung cancer screening sites.

Our team analyzed survey data from our SCOE network of over 600 lung cancer screening programs committed to following best practice protocols during the first year of insurance coverage for lung cancer screening.  The paper shares important information about an effective screening program framework that others may use to evaluate and improve their programs.

While this data validates our SCOE network as a fundamental tool in defining high-quality and effective lung cancer screening, screening is still a relatively new practice which faces barriers. More than 50% of screening program representatives in the study reported that insurance and billing issues, lack of patient awareness about screening availability, internal workflow issues, and problems with provider referrals were barriers for their program. These findings highlight the immense value of our SCOE network, while also underlining the opportunity to address barriers and increase the impact of screening for our community.

Congratulations to our science and research and excellence in screening and care teams for this major accomplishment.

You can access the full publication for free! Click here to view or download.